Apixaban News and Research

RSS
Study: Most stroke survivors can safely take two types of common antidepressants

Study: Most stroke survivors can safely take two types of common antidepressants

Common oral anticoagulant rivaroxaban linked to highest risk of bleeding complications

Common oral anticoagulant rivaroxaban linked to highest risk of bleeding complications

Major trial finds apixaban reduces stroke risk in patients with device-detected atrial fibrillation

Major trial finds apixaban reduces stroke risk in patients with device-detected atrial fibrillation

Modern blood thinners linked to reduced risk of bleeding

Modern blood thinners linked to reduced risk of bleeding

Do system-level DOAC therapy management services affect anticoagulation outcomes for AF patients compared to usual care?

Do system-level DOAC therapy management services affect anticoagulation outcomes for AF patients compared to usual care?

A randomized trial of a blood thinner after severe COVID-19 to prevent clotting events

A randomized trial of a blood thinner after severe COVID-19 to prevent clotting events

High-dose anticoagulation can reduce deaths, intubations in hospitalized COVID-19 patients

High-dose anticoagulation can reduce deaths, intubations in hospitalized COVID-19 patients

Non-critically ill hospitalized Covid-19 patients could substantially benefit from a higher dose of blood-thinners

Non-critically ill hospitalized Covid-19 patients could substantially benefit from a higher dose of blood-thinners

Dual antiplatelet therapy for minor or a warning stroke is underused especially among women

Dual antiplatelet therapy for minor or a warning stroke is underused especially among women

Research offers a cost-effectiveness analysis of anticoagulant drugs for cancer-associated thrombosis

Research offers a cost-effectiveness analysis of anticoagulant drugs for cancer-associated thrombosis

Cost-effectiveness analysis of four interventions for treatment of cancer-associated thrombosis

Cost-effectiveness analysis of four interventions for treatment of cancer-associated thrombosis

Direct oral anticoagulants more effective and cost-effective for treating cancer-associated thrombosis

Direct oral anticoagulants more effective and cost-effective for treating cancer-associated thrombosis

Common psychiatric medications can give some protection against COVID-19

Common psychiatric medications can give some protection against COVID-19

No benefit of low dose apixaban following acute COVID-19

No benefit of low dose apixaban following acute COVID-19

Oral anticoagulant does not help patients recovering from moderate and severe COVID-19

Oral anticoagulant does not help patients recovering from moderate and severe COVID-19

Oral anticoagulant drug may be safe, effective in preventing blood clots after urologic cancer surgery

Oral anticoagulant drug may be safe, effective in preventing blood clots after urologic cancer surgery

Clinical presentation of monkeypox infection in two Israeli males

Clinical presentation of monkeypox infection in two Israeli males

Low-dose apixaban treatment reduces recurrence of venous thromboembolism compared to anticoagulant discontinuation after negative D-dimer

Low-dose apixaban treatment reduces recurrence of venous thromboembolism compared to anticoagulant discontinuation after negative D-dimer

Many treatments for intracerebral hemorrhage are not as effective as previously thought, guideline suggests

Many treatments for intracerebral hemorrhage are not as effective as previously thought, guideline suggests

New type of anti-clotting drug reduces bleeding incidents among patients with atrial fibrillation

New type of anti-clotting drug reduces bleeding incidents among patients with atrial fibrillation